Microbiological Diagnosis of Infectious Uveitis to Pathogenic Fastidious Germs

Overview

Our research project is to use a new microbiological diagnostic strategy of uveitis, allowing detection of the fastidious pathogens of infectious Uveitis who are not diagnosed by laboratory methods used in diagnostic routine. This new diagnostic strategy is to automatically detect the presence of a pathogen fastidious in cell culture using the same patient's serum to reveal a positive culture, based on the assumption that this serum contains antibodies specific pathogen tedious. Finally, the main purpose of this study is to improve the etiological diagnosis of Uveitis by establishing a new diagnostic strategy.

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: N/A
    • Intervention Model: Single Group Assignment
    • Primary Purpose: Diagnostic
    • Masking: None (Open Label)
  • Study Primary Completion Date: March 6, 2019

Detailed Description

The Mediterranean Infection microbiology laboratory is the national Reference Laboratory for the diagnosis of infectious Uveitis. The essential problem of the Uveitis is the etiological diagnosis since currently in 60% of cases no etiological diagnosis is brought out despite the deployment of routine diagnostic tests. The prognosis of the Uveitis is generally good but 15% approximately of Uveitis are evolving on a chronic mode which decreased faster than the Visual acuity of the eye reached that can lead to blindness in bilateral cases of Uveitis. Different works of the literature identified a few pathogenic microorganisms, viruses and bacteria as being responsible for uveitis, including within the particular framework of the endophtalmies. Recent work allowed to highlight the place of fastidious bacteria (Bartonella spp., Tropheryma whipplei, Rickettsia spp., Coxiella burnetii, Borrelia spp.) in these Uveitis. Despite all his investigations, is estimated that 20-30% of Uveitis likely to be of infectious origin are not documented by the methods used in routine. Our research project is to use a new microbiological diagnostic strategy of uveitis, allowing detection of the fastidious pathogens of infectious Uveitis who are not diagnosed by laboratory methods used in diagnostic routine. This new diagnostic strategy is to automatically detect the presence of a pathogen fastidious in cell culture using the same patient's serum to reveal a positive culture, based on the assumption that this serum contains antibodies specific pathogen tedious.

Interventions

  • Other: Blood sampling
    • Detection of bacteria will be performed on a blood sample

Arms, Groups and Cohorts

  • Other: Uveitis
    • Patient with a prescription of a microbiologic diagnostic of uveitis

Clinical Trial Outcome Measures

Primary Measures

  • Percentage of patients with an etiological diagnosis of Uveitis
    • Time Frame: 1 day

Secondary Measures

  • Number of fastidious pathogenic germs detected
    • Time Frame: 1 day

Participating in This Clinical Trial

Inclusion Criteria

* Patient is more than 18 years old.

  • Patient with a prescription of a microbiologic diagnostic of uveitis – Patient who do not declined to have his medical records reviewed for research – Patient with health insurance Exclusion Criteria:

* Minor Patient ( age <18 years) (L. 1121-7 ) .

  • Pregnant woman , parturient or nursing (L. 1121-5 ) . – Patient major under guardianship (L. 1121-8 ) . – Patient vital in emergency. – Patient refusing to sign the informed consent form . – Patient deprived of liberty under court order (L. 1121-6 ) .

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Assistance Publique Hopitaux De Marseille
  • Provider of Information About this Clinical Study
    • Sponsor
  • Overall Official(s)
    • Catherine GEINDRE, Study Director, Assistance publique hôpitaux de marseille

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.